@PharmatechAI

Pharmatech AI ($PCH) claims to combine AI-driven drug discovery with a 620k sqm research center in Germany and cannabis cultivation labs.

The project has a token in presale stage, runs Zealy campaigns offering $70k in rewards, and announces multiple partnerships.

However, the account is brand new (March 2025), has minimal organic following (1,053), and exhibits patterns common to crypto presale projects rather than legitimate pharmaceutical research operations.

The grand claims (600k sqm facility, $137B market, AI analyzing 5M+ molecular interactions) lack independent verification, and no credible team information or institutional backing is visible.

Green flags: Detailed whitepaper and technical documentation on AI-MDIP model · Specific claims about research infrastructure (60 hectares, 55 MWp solar) · Partnership announcements with crypto projects (Router Protocol, QuantifAI)

Red flags: Account created March 2025 with only 1,053 followers - extremely early with minimal traction · Heavy presale focus and Zealy reward campaigns ($70k giveaways) -典型 crypto marketing not pharma research · Anonymous team, no verifiable credentials, no institutional pharmaceutical partnerships · Grand claims (600k sqm facility, $137B market) with zero independent verification or credible evidence · Cannabis + AI + blockchain combination raises regulatory and credibility concerns for pharma space